Shenzhen Lifotronic Technology Co., Ltd.
688389.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.85B
Close$
Share Statistics
| Market cap | $4.85 Billion |
|---|---|
| Enterprise Value | $3.86 Billion |
| Dividend Yield | $0.28 (2.49%) |
| Earnings per Share | $0.43 |
| Beta | 0.44 |
| Outstanding Shares | 428,485,730 |
Return
| Return on Equity | 6.92% |
|---|---|
| Return on Assets | 5.49% |
| Return on Invested Capital | 7.29% |
Valuation & Multiples
| P/E Ratio | 33.21 |
|---|---|
| PEG | -106.84 |
| Price to Sales | 5.66 |
| Price to Book Ratio | 2.83 |
| Enterprise Value to Revenue | 3.41 |
| Enterprise Value to EBIT | 25.55 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 22, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$343.95 M
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$343.75 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shenzhen Lifotronic Technology Co., Ltd.
1,896 employees
CEO: Ming Long Hu Established in 2008 and headquartered in Shenzhen, China, Shenzhen Lifotronic Technology Co., Ltd. specializes in the design, production, and distribution of a wide range of medical devices throughout China, addressing both diagnostic an...